R John Fletcher
CIK 1215024 · last filed 2026-10-02
R John Fletcher is a corporate insider who has filed 151 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider was granted $12.1K of CLPT on Oct 2, 2026. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACLS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HINGHAM, MA 02043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLPT | Director | 132,004 | $9.17 | $1.21M | $0 | 38 | 2026-10-02 |
| KRMD | Director | 239,836 | $3.23 | $774.7K | $207.6K | 32 | 2026-10-01 |
| OptiNose, Inc. (OPTN) Delisted | Director | — | $9.60 | — | $0 | 4 | 2025-05-21 |
| Vyant Bio, Inc. (VYNT) Delisted | Director | 29,955 | $0.19 | $5.8K | $101.8K | 9 | 2023-01-19 |
| ACLS | Director | 1,354 | $107.64 | $145.7K | -$2.96M | 23 | 2021-02-17 |
| SPECTRANETICS CORP (SPNC) Delisted | Director | 141,697 | — | — | -$403.2K | 17 | 2017-06-12 |
| Adhera Therapeutics, Inc. (MRNAD) Delisted | Director | — | — | — | $0 | 1 | 2011-09-07 |
| PANACOS PHARMACEUTICALS, INC. (PANC) Delisted | Director | — | — | — | $0 | 3 | 2008-06-30 |
Recent Filings
151 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-02 | CLPT | Grant (A) | +993 | $12.1K | EDGAR |
| 2026-10-01 | KRMD | Grant (A) | +7,679 | $22.5K | EDGAR |
| 2026-07-06 | CLPT | Grant (A) | +662 | $11.8K | EDGAR |
| 2026-07-01 | KRMD | Grant (A) | +5,357 | $22.5K | EDGAR |
| 2026-05-26 | CLPT | Grant (A) | — | $0 | EDGAR |
| 2026-05-21 | CLPT | Exer (M) | +12,417 | $0 | EDGAR |
| 2026-04-02 | CLPT | Grant (A) | +1,270 | $11.6K | EDGAR |
| 2026-04-01 | KRMD | Grant (A) | +5,208 | $22.5K | EDGAR |
| 2026-01-05 | CLPT | Grant (A) | +422 | $5.8K | EDGAR |
| 2026-01-02 | KRMD | Grant (A) | +3,872 | $22.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.